InvestorsHub Logo
Followers 3
Posts 582
Boards Moderated 0
Alias Born 01/19/2012

Re: StocksInvestor post# 5328

Tuesday, 06/05/2018 8:37:12 PM

Tuesday, June 05, 2018 8:37:12 PM

Post# of 7763

Imetelstat, Telomerase Inhibitor Myelofibrosis Intravenous drug given every 3-4 weeks


Description: John Mascarenhas, MD, Mount Sinai School of Medicine, discusses Imetelstat, Telomerase Inhibitor Myelofibrosis Intravenous drug given every 3-4 weeks at Imedex Great Debates 2018.
posted on: 4/19/18

Janssen does not permit anyone to talk about reversal of fibrosis when they give presentations. Dr Mascarenhas comment of OS is the topic of the MF CT.

http://www.oncologytube.com/video/imetelstat-telomerase-inhibitor-myelofibrosis-intravenous-drug-given-every-3-4-weeks/10003699
Less
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News